CAR-T vs. Bispecific Antibodies: A Treatment Showdown
In a groundbreaking development in oncology, a recent meta-analysis has emerged, providing an extensive comparative evaluation of Chimeric Antigen Receptor T-cell (CAR-T) therapy and bispecific...















